• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Nutraplus India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524764
INE230G01020
-1.6703654
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
7.16
EPS(TTM)
Face Value()
Div & Yield %
0
5
0
 

Vivo Bio Tech reports consolidated net loss of Rs 5.16 crore in the March 2026 quarter
Jun 01,2026
Net loss of Vivo Bio Tech reported to Rs 5.16 crore in the quarter ended March 2026 as against net profit of Rs 1.06 crore during the previous quarter ended March 2025. Sales rose 15.54% to Rs 14.20 crore in the quarter ended March 2026 as against Rs 12.29 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.71 crore in the year ended March 2026 as against net profit of Rs 7.28 crore during the previous year ended March 2025. Sales rose 14.27% to Rs 53.33 crore in the year ended March 2026 as against Rs 46.67 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales14.2012.29 16 53.3346.67 14
OPM %31.3440.85 -39.1043.95 -
PBDT3.003.49 -14 15.4417.81 -13
PBT0.251.24 -80 4.818.79 -45
NP-5.161.06 PL -1.717.28 PL